Building the European-Australian Research Community

FEASTtweet @ Twitter

• 17/02/2010 ERC Starting Grant trailer [link]
• 16/02/2010 RT @KevinRuddPM Nominate a science champion for PM’S Prizes for Science [link]
• 22/01/2010 Jean-François is now working in International Collaborations at the Qld DEEDI [link]
• 08/12/2009 The Australian Government has launched an inquiry into Australia’s international research collaboration. [link]

follow us…

Opportunities

• 09/03/2010 ANU Centre for European Studies Visiting Fellowships
• 03/03/2010 Australia Council for the Arts Residencies in Europe
• 03/03/2010 Swedish Research Council for Working Life and Social Research: Outgoing & Incoming Fellowships
• 25/02/2010 Fellowships in Florence

more opportunities…

Diary

• 26/03/2010 DAAD Alumni Conference "Tackling the Future"
• 29/03/2010 IOP Annual Conference on Plasma Physics
• 12/04/2010 PLASMA Diagnostics 2010
• 18/04/2010 5^th EPSO Conference: “Plants for Life”

more events…

Why SMEs succeed in EU research projects

by CORDIS

What are the performance factors that strengthen participation of small and medium-sized enterprises (SMEs) in the health and biotechnology fields? The KAPPA-Health (‘Key performance factor assessment and valorisation for successful EU-FP project participation of innovation SMEs in the area of health’) project is finding out. KAPPA-Health is backed with almost €750,000 in funding under the Health Theme of the EU’s Seventh Framework Programme (FP7).

Researchers have made great strides in fuelling biotechnology, medical technologies and bioengineering, which in turn have helped strengthen the field of medical research. However, there are a number of obstacles involved when trying to bring medical products and services to market. Entrepreneurs may be very willing to commercialise their inventions but one crucial factor either makes or breaks its commercial success: financing.

Healthcare biotechnology is more often than not a casualty, because product development may actually take more than a decade before the product hits the shelves. Businesses need external funding for extensive periods to ensure their high-quality research and development activities.

The EU’s Sixth and Seventh Framework Programmes (FP6 and FP7 respectively) are instrumental in providing critical financial support to such businesses. Ask SMEs if they think their participation in EU-funded projects is a success and more than 90% will give a resounding yes. Half of these SMEs have already yielded commercial return.

In the first phase of the project, the KAPPA-Health partners assessed almost 200 SMEs to identify the performance factors that triggered their success. The results of their assessment would benefit companies eyeing participation in an EU-funded project. In the second phase of the project, the partners are conducting in-depth interviews and analysis on another 40 enterprises. Of the SMEs interviewed by the KAPPA-Health team, 50% said their participation in an EU-funded project was a success.

Up to 80% of the SMEs polled said the biggest upshot for participating in these projects was obtaining greater knowledge. They also highlighted the fact that the EU projects helped them expand their network, build a stronger client base, access complementary expertise and gain stronger footholds on the global market.

It should be noted that posting commercially exploitable results was not cited as an objective since the criteria for participating in such projects is to develop pre-competitive scientific research, the partners say. More than three quarters of the businesses that have taken part in projects stipulate that the research is consistent with their core activity.

The KAPPA-Health partners also found that around 80% of successful SMEs took part in more than 1 project, while 83% of the projects generate research contacts, and 50% business contacts. SMEs favour taking part in small or medium-sized projects because they are easier to handle, according to the researchers.

Read the full article | More articles

25/02/2010